Documenting stage 1 and 2 meaningful use criteria

A comparison of clinical pharmacists with other healthcare providers

Osamah M. Alfayez, Sandra Leal, Terri L Warholak

Research output: Contribution to journalArticle

Abstract

Purpose. Documentation of Stage 1 and Stage 2 Meaningful Use (MU) criteria for patients with type 2 diabetes mellitus between clinical pharmacists and other healthcare providers was compared. Methods. Patients seen at 8 clinics in a federally qualified health center who had type 2 diabetes mellitus and were seen by clinical pharmacists or other healthcare providers were randomly selected for inclusion in this retrospective study. Approximately half of the encounters were evaluated for Stage 1 MU compliance (encounters from October through December 2014), and half were evaluated for Stage 2 MU compliance (encounters from January through March 2015). Categorical and descriptive variables were analyzed by calculating frequencies and percentages. Chi-square tests were used to compare groups with an a priori level of significance set at 0.05. Results. A total of 790 patients were seen by 46 providers, 8 (18%) of whom were clinical pharmacists. The study also included 24 medical doctors, 8 family nurse practitioners, 1 physician assistant, and 5 doctors of osteopathic medicine. Other healthcare providers more consistently documented 5 Stage 1 MU criteria than did clinical pharmacists. Clinical pharmacists more consistently documented 2 core objectives than did other healthcare providers. Otherwise, no significant differences in documentation were detected. Conclusion. Other healthcare providers more consistently documented 5 Stage 1 MU criteria than did clinical pharmacists. Clinical pharmacists more consistently documented 2 core objectives than did other healthcare providers.

Original languageEnglish (US)
Pages (from-to)S24-S28
JournalAmerican Journal of Health-System Pharmacy
Volume75
Issue number5
DOIs
StatePublished - Mar 1 2018

Fingerprint

Pharmacists
Health Personnel
Documentation
Type 2 Diabetes Mellitus
Compliance
Family Nurse Practitioners
Osteopathic Medicine
Physician Assistants
Chi-Square Distribution
Retrospective Studies
Health

Keywords

  • Ambulatory care
  • Centers for Medicare and Medicaid Services
  • Clinical pharmacist
  • Electronic health record
  • Meaningful use
  • Type 2 diabetes mellitus

ASJC Scopus subject areas

  • Pharmacology
  • Health Policy

Cite this

Documenting stage 1 and 2 meaningful use criteria : A comparison of clinical pharmacists with other healthcare providers. / Alfayez, Osamah M.; Leal, Sandra; Warholak, Terri L.

In: American Journal of Health-System Pharmacy, Vol. 75, No. 5, 01.03.2018, p. S24-S28.

Research output: Contribution to journalArticle

@article{82f27b624dd3485194ad250f6e07283e,
title = "Documenting stage 1 and 2 meaningful use criteria: A comparison of clinical pharmacists with other healthcare providers",
abstract = "Purpose. Documentation of Stage 1 and Stage 2 Meaningful Use (MU) criteria for patients with type 2 diabetes mellitus between clinical pharmacists and other healthcare providers was compared. Methods. Patients seen at 8 clinics in a federally qualified health center who had type 2 diabetes mellitus and were seen by clinical pharmacists or other healthcare providers were randomly selected for inclusion in this retrospective study. Approximately half of the encounters were evaluated for Stage 1 MU compliance (encounters from October through December 2014), and half were evaluated for Stage 2 MU compliance (encounters from January through March 2015). Categorical and descriptive variables were analyzed by calculating frequencies and percentages. Chi-square tests were used to compare groups with an a priori level of significance set at 0.05. Results. A total of 790 patients were seen by 46 providers, 8 (18{\%}) of whom were clinical pharmacists. The study also included 24 medical doctors, 8 family nurse practitioners, 1 physician assistant, and 5 doctors of osteopathic medicine. Other healthcare providers more consistently documented 5 Stage 1 MU criteria than did clinical pharmacists. Clinical pharmacists more consistently documented 2 core objectives than did other healthcare providers. Otherwise, no significant differences in documentation were detected. Conclusion. Other healthcare providers more consistently documented 5 Stage 1 MU criteria than did clinical pharmacists. Clinical pharmacists more consistently documented 2 core objectives than did other healthcare providers.",
keywords = "Ambulatory care, Centers for Medicare and Medicaid Services, Clinical pharmacist, Electronic health record, Meaningful use, Type 2 diabetes mellitus",
author = "Alfayez, {Osamah M.} and Sandra Leal and Warholak, {Terri L}",
year = "2018",
month = "3",
day = "1",
doi = "10.2146/ajhp170150",
language = "English (US)",
volume = "75",
pages = "S24--S28",
journal = "American Journal of Health-System Pharmacy",
issn = "1079-2082",
publisher = "American Society of Health-Systems Pharmacy",
number = "5",

}

TY - JOUR

T1 - Documenting stage 1 and 2 meaningful use criteria

T2 - A comparison of clinical pharmacists with other healthcare providers

AU - Alfayez, Osamah M.

AU - Leal, Sandra

AU - Warholak, Terri L

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Purpose. Documentation of Stage 1 and Stage 2 Meaningful Use (MU) criteria for patients with type 2 diabetes mellitus between clinical pharmacists and other healthcare providers was compared. Methods. Patients seen at 8 clinics in a federally qualified health center who had type 2 diabetes mellitus and were seen by clinical pharmacists or other healthcare providers were randomly selected for inclusion in this retrospective study. Approximately half of the encounters were evaluated for Stage 1 MU compliance (encounters from October through December 2014), and half were evaluated for Stage 2 MU compliance (encounters from January through March 2015). Categorical and descriptive variables were analyzed by calculating frequencies and percentages. Chi-square tests were used to compare groups with an a priori level of significance set at 0.05. Results. A total of 790 patients were seen by 46 providers, 8 (18%) of whom were clinical pharmacists. The study also included 24 medical doctors, 8 family nurse practitioners, 1 physician assistant, and 5 doctors of osteopathic medicine. Other healthcare providers more consistently documented 5 Stage 1 MU criteria than did clinical pharmacists. Clinical pharmacists more consistently documented 2 core objectives than did other healthcare providers. Otherwise, no significant differences in documentation were detected. Conclusion. Other healthcare providers more consistently documented 5 Stage 1 MU criteria than did clinical pharmacists. Clinical pharmacists more consistently documented 2 core objectives than did other healthcare providers.

AB - Purpose. Documentation of Stage 1 and Stage 2 Meaningful Use (MU) criteria for patients with type 2 diabetes mellitus between clinical pharmacists and other healthcare providers was compared. Methods. Patients seen at 8 clinics in a federally qualified health center who had type 2 diabetes mellitus and were seen by clinical pharmacists or other healthcare providers were randomly selected for inclusion in this retrospective study. Approximately half of the encounters were evaluated for Stage 1 MU compliance (encounters from October through December 2014), and half were evaluated for Stage 2 MU compliance (encounters from January through March 2015). Categorical and descriptive variables were analyzed by calculating frequencies and percentages. Chi-square tests were used to compare groups with an a priori level of significance set at 0.05. Results. A total of 790 patients were seen by 46 providers, 8 (18%) of whom were clinical pharmacists. The study also included 24 medical doctors, 8 family nurse practitioners, 1 physician assistant, and 5 doctors of osteopathic medicine. Other healthcare providers more consistently documented 5 Stage 1 MU criteria than did clinical pharmacists. Clinical pharmacists more consistently documented 2 core objectives than did other healthcare providers. Otherwise, no significant differences in documentation were detected. Conclusion. Other healthcare providers more consistently documented 5 Stage 1 MU criteria than did clinical pharmacists. Clinical pharmacists more consistently documented 2 core objectives than did other healthcare providers.

KW - Ambulatory care

KW - Centers for Medicare and Medicaid Services

KW - Clinical pharmacist

KW - Electronic health record

KW - Meaningful use

KW - Type 2 diabetes mellitus

UR - http://www.scopus.com/inward/record.url?scp=85042690000&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042690000&partnerID=8YFLogxK

U2 - 10.2146/ajhp170150

DO - 10.2146/ajhp170150

M3 - Article

VL - 75

SP - S24-S28

JO - American Journal of Health-System Pharmacy

JF - American Journal of Health-System Pharmacy

SN - 1079-2082

IS - 5

ER -